OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host variables confound gut microbiota studies of human disease
Ivan Vujkovic-Cvijin, Jack Sklar, Lingjing Jiang, et al.
Nature (2020) Vol. 587, Iss. 7834, pp. 448-454
Open Access | Times Cited: 429

Showing 26-50 of 429 citing articles:

Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes
Bingting Chen, Yu Bai, Fenglian Tong, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54

Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome
Lixiang Zhai, Haitao Xiao, Chengyuan Lin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 52

Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
Éloi Gagnon, Patricia L. Mitchell, Hasanga D. Manikpurage, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 48

Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease
Xin Zhou, Xiaotao Shen, Jethro S. Johnson, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 4, pp. 506-526.e9
Open Access | Times Cited: 47

Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ
María Eugenia Inda, Miguel Jiménez, Qijun Liu, et al.
Nature (2023) Vol. 620, Iss. 7973, pp. 386-392
Closed Access | Times Cited: 44

Microbiome as a biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22

Lactic acid fermentation of goji berries (Lycium barbarum) prevents acute alcohol liver injury and modulates gut microbiota and metabolites in mice
Wenhui Duan, Lingxi Zhou, Yilin Ren, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1612-1626
Closed Access | Times Cited: 16

Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils
Dharti Shantaram, Rebecca Hoyd, Alecia Blaszczak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16

Integration of 168,000 samples reveals global patterns of the human gut microbiome
Richard J. Abdill, Samantha P. Graham, Vincent Rubinetti, et al.
Cell (2025)
Open Access | Times Cited: 3

Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
Patrice D. Cani, Emilie Moens de Hase, Matthias Van Hul
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1302-1302
Open Access | Times Cited: 77

Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease
Brandon Khor, Michael Snow, Elisa Herrman, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 496-496
Open Access | Times Cited: 75

The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Reece J. Knippel, Julia L. Drewes, Cynthia L. Sears
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2378-2395
Open Access | Times Cited: 75

Gut microbiota-mediated immunomodulation in tumor
Xinyi Liu, Yanjie Chen, Si Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 68

Prebiotics and the Human Gut Microbiota: From Breakdown Mechanisms to the Impact on Metabolic Health
Cassandre Bedu-Ferrari, Paul Biscarrat, Philippe Langella, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2096-2096
Open Access | Times Cited: 64

Harnessing machine learning for development of microbiome therapeutics
Laura E. McCoubrey, Moe Elbadawi, Mine Orlu, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 62

Acetate reprograms gut microbiota during alcohol consumption
Cameron Martino, Lívia S. Zaramela, Bei Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 62

Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder
Mingxing Lou, Aihua Cao, Cuiyuan Jin, et al.
Gut (2021), pp. gutjnl-325115
Open Access | Times Cited: 59

Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics
Daniel Podlesny, Marija Durdević, Sudarshan Paramsothy, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 8, pp. 100711-100711
Open Access | Times Cited: 57

Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls
Stefanie Malan‐Müller, Mireia Vallès-Colomer, Christine L. Foxx, et al.
European Neuropsychopharmacology (2021) Vol. 56, pp. 24-38
Open Access | Times Cited: 56

Fungal microbiome in inflammatory bowel disease: a critical assessment
David M. Underhill, Jonathan Braun
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 56

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome
Qi Su, Hein M. Tun, Qin Liu, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 56

The microbiota and the gut–liver axis in primary sclerosing cholangitis
Johannes R. Hov, Tom H. Karlsen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 135-154
Closed Access | Times Cited: 53

Cross-sectional associations between the gut microbe Ruminococcus gnavus and features of the metabolic syndrome: the HUNT study
Louise Grahnemo, Maria Nethander, Eivind Coward, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 7, pp. 481-483
Closed Access | Times Cited: 52

How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?
Bram Verstockt, Miles Parkes, James Lee
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1383-1395
Open Access | Times Cited: 47

Scroll to top